A High-Affinity Peptide Ligand Targeting Syntenin Inhibits Glioblastoma

Haugaard-Kedstrom, LM; Clemmensen, LS; Sereikaite, V; Jin, ZY; Fernandes, EFA; Wind, B; Abalde-Gil, F; Daberger, J; Vistrup-Parry, M; Aguilar-Morante, D; Leblanc, R; Egea-Jimenez, AL; Albrigtsen, M; Jensen, KE; Jensen, TMT; Ivarsson, Y; Vincentelli, R; Hamerlik, P; Andersen, JH; Zimmermann, P; Lee, W; Stromgaard, K

Haugaard-Kedstrom, LM; Stromgaard, K (corresponding author), Univ Copenhagen, Ctr Biopharmaceut, Dept Drug Design & Pharmacol, DK-2100 Copenhagen, Denmark.; Lee, W (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea.

JOURNAL OF MEDICINAL CHEMISTRY, 2021; 64 (3): 1423

Abstract

Despite the recent advances in cancer therapeutics, highly aggressive cancer forms, such as glioblastoma (GBM), still have very low survival rates. Th......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索